Citeline’s VP of commercial, patient engagement, and recruitment discusses how clinical trial design must adapt to modern issues.
Matt Holms, MBA
Advertisement
Matt Holms, MBA is VP of commercial, patient engagement, and recruitment at Citeline.
Articles by Matt Holms, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Amgen’s Tarlatamab Approved in China
2
Pharmaceutical Executive Daily: China Approves Amgen's Tarlatamab for Previously Treated Extensive-Stage Small Cell Lung Cancer
3
Roche and C4 Therapeutics Expands Partnership with $1 Billion Collaboration Agreement
4
Shionogi Inc. Awarded $482 Million Contract with U.S. Government to Enhance National Preparedness for Drug-Resistant Bacterial Threats
5